Literature DB >> 31806743

Draft Genome Sequences of Mycobacterium tuberculosis Clinical Isolates from the Ural Region of Russia That Carry the pks15/1 Gene.

Kirill V Shur1, Natalia V Zakharevich2, Natalia I Akimova2, Roman A Yunes2, Svetlana G Frolova2, Dmitry A Maslov2, Valery N Danilenko2.   

Abstract

Here, we report the draft genome sequences of 15 Mycobacterium tuberculosis isolates of the Beijing-B0/W-148 sublineage that carry a 7-bp insertion within the pks15 gene, which leads to the synthesis of Pks15/1 fusion protein. Pks15/1 is involved in phenolglycolipid synthesis and biofilm formation, thus potentially contributing to the B0/W-148 lineage's enhanced virulence and drug resistance.
Copyright © 2019 Shur et al.

Entities:  

Year:  2019        PMID: 31806743      PMCID: PMC6895303          DOI: 10.1128/MRA.01126-19

Source DB:  PubMed          Journal:  Microbiol Resour Announc        ISSN: 2576-098X


ANNOUNCEMENT

Mycobacterium tuberculosis virulence and pathogenicity are determined by a set of genes which are polymorphic in different phylogenetic lineages (1–3). The M. tuberculosis Beijing genotype has the widest spread; in Russia, it includes the “successful” clone Beijing B0/W-148, which is characterized as multidrug resistant (MDR) and highly virulent (4–6). Therefore, it is very important to analyze lineage-specific virulence and pathogenicity markers. One significant marker is the 7-bp insertion in the pks15 gene (CCGCGGC) that leads to the synthesis of an active fused Pks15/1 protein (7). Presence of the pks15/1 gene is correlated with highly virulent and drug-resistant strains of the Beijing genotype (8–10); it plays a significant role in virulence (via phenolic glycolipid synthesis) and may be involved in drug tolerance mediated by biofilm formation (7, 9, 11). Studying the genetic variability of virulence factors such as pks15/1 is essential for understanding the M. tuberculosis evolutionary process, including the evolution of host-pathogen interaction mechanisms and drug resistance. Thus, we provide the whole-genome sequencing data of 15 strains from a collection of 100 MDR M. tuberculosis Beijing-B0/W-148 strains (12) that carry a copy of the fused pks15/1 gene. M. tuberculosis was cultured in Middlebrook 7H9 medium with the addition of oleic acid-albumin-dextrose-catalase (OADC; HiMedia, India) at 37°C for 4 weeks. Genomic DNA was isolated and purified by phenol-chloroform/isoamyl alcohol extraction after enzymatic cell lysis, as described by Belisle et al. (13). The quality of DNA was checked using gel electrophoresis and a Bioanalyzer 2100 instrument (Agilent Technologies, USA). Genomic DNA libraries were prepared using the NEBNext Ultra II DNA library prep kit for Illumina (New England Biolabs, USA). The raw sequencing data were obtained using the HiSeq 2500 platform (Illumina, USA) in rapid run mode with a HiSeq Rapid sequencing by synthesis (SBS) kit v2 (2 ×100 bp; Illumina). The quality check of the reads was done using FastQC v.0.11.7 (14). Illumina reads were de novo assembled using SPAdes v.3.12.0 (15) with the -careful flag and k-mers of 21, 33, 55, and 77, while assembly metrics were calculated with QUAST v.5.0.2 with default parameters (16). Automatic functional annotation results were obtained using the NCBI Prokaryotic Genome Annotation Pipeline. Characteristics of the sequenced genomes are listed in Table 1.
TABLE 1

Characteristics of 15 M. tuberculosis genome assemblies with the pks15/1 gene

IsolateWGS (GenBank) accession no.SRA accession no.Genome size (bp)GC content (%)Coverage (×)No. of contigsTotal no. of CDSsa
EKB1VOVK00000000SRR83272164,366,76465.299120139
EKB3VOVL00000000SRR83278604,366,22764.599129141
EKB10VOVM00000000SRR84427614,372,73365.5100143139
EKB12VOVN00000000SRR83350264,366,32865.699113139
EKB23VOVO00000000SRR83475384,365,63365.599105141
EKB28VOVP00000000SRR83519214,362,71365.59995138
EKB29VOVQ00000000SRR83524624,366,36465.1100129143
EKB35VOVR00000000SRR83534834,365,17265.499106143
EKB37VOVS00000000SRR83543364,364,82765.499108136
EKB40VOVT00000000SRR83547174,359,31565.499103145
EKB46VOVU00000000SRR83574464,358,59765.499100135
EKB59VOVV00000000SRR83658944,367,94765.399121134
EKB75VOVW00000000SRR83698944,361,20964.399121143
EKB77VOVX00000000SRR83701304,361,09965.099123144
EKB84VOVY00000000SRR83799014,360,81665.099132144

CDS, coding sequence.

Characteristics of 15 M. tuberculosis genome assemblies with the pks15/1 gene CDS, coding sequence.

Data availability.

The whole-genome shotgun (WGS) assemblies described here have been deposited in NCBI GenBank. The versions described in this paper are the first versions. The read archives have been deposited in NCBI SRA. The WGS (GenBank) and SRA accession numbers are listed in Table 1. All of the data are part of BioProject identifier (ID) PRJNA509547.
  12 in total

1.  A rapid PCR assay to characterize the intact pks15/1 gene, a virulence marker in Mycobacterium tuberculosis.

Authors:  Roberto Zenteno-Cuevas; Rodrigo Javier Hernandez-Morales; Lucia Monserrat Pérez-Navarro; Raquel Muñiz-Salazar; Juan Santiago-García
Journal:  J Microbiol Methods       Date:  2015-12-08       Impact factor: 2.363

Review 2.  Virulence factors of the Mycobacterium tuberculosis complex.

Authors:  Marina A Forrellad; Laura I Klepp; Andrea Gioffré; Julia Sabio y García; Hector R Morbidoni; María de la Paz Santangelo; Angel A Cataldi; Fabiana Bigi
Journal:  Virulence       Date:  2012-10-17       Impact factor: 5.882

3.  QUAST: quality assessment tool for genome assemblies.

Authors:  Alexey Gurevich; Vladislav Saveliev; Nikolay Vyahhi; Glenn Tesler
Journal:  Bioinformatics       Date:  2013-02-19       Impact factor: 6.937

4.  The polyketide Pks1 contributes to biofilm formation in Mycobacterium tuberculosis.

Authors:  Jennifer M Pang; Emilie Layre; Lindsay Sweet; Ashley Sherrid; D Branch Moody; Anil Ojha; David R Sherman
Journal:  J Bacteriol       Date:  2011-11-28       Impact factor: 3.490

5.  Russian "successful" clone B0/W148 of Mycobacterium tuberculosis Beijing genotype: a multiplex PCR assay for rapid detection and global screening.

Authors:  Igor Mokrousov; Olga Narvskaya; Anna Vyazovaya; Tatiana Otten; Wei-Wei Jiao; Lia Lima Gomes; Philip N Suffys; A-Dong Shen; Boris Vishnevsky
Journal:  J Clin Microbiol       Date:  2012-08-29       Impact factor: 5.948

Review 6.  [The virulence factors of Mycobacterium tuberculosis: genetic control, new conceptions].

Authors:  A A Prozorov; I A Fedorova; O B Bekker; V N Danilenko
Journal:  Genetika       Date:  2014-08

7.  Role of the pks15/1 gene in the biosynthesis of phenolglycolipids in the Mycobacterium tuberculosis complex. Evidence that all strains synthesize glycosylated p-hydroxybenzoic methyl esters and that strains devoid of phenolglycolipids harbor a frameshift mutation in the pks15/1 gene.

Authors:  Patricia Constant; Esther Perez; Wladimir Malaga; Marie-Antoinette Lanéelle; Olivier Saurel; Mamadou Daffé; Christophe Guilhot
Journal:  J Biol Chem       Date:  2002-07-22       Impact factor: 5.157

8.  Mycobacterium tuberculosis Beijing genotype in Russia: in search of informative variable-number tandem-repeat loci.

Authors:  Igor Mokrousov; Olga Narvskaya; Anna Vyazovaya; Julie Millet; Tatiana Otten; Boris Vishnevsky; Nalin Rastogi
Journal:  J Clin Microbiol       Date:  2008-08-27       Impact factor: 5.948

9.  Mycobacterium tuberculosis lineage influences innate immune response and virulence and is associated with distinct cell envelope lipid profiles.

Authors:  Nitya Krishnan; Wladimir Malaga; Patricia Constant; Maxine Caws; Thi Hoang Chau Tran; Jenifer Salmons; Thi Ngoc Lan Nguyen; Duc Bang Nguyen; Mamadou Daffé; Douglas B Young; Brian D Robertson; Christophe Guilhot; Guy E Thwaites
Journal:  PLoS One       Date:  2011-09-08       Impact factor: 3.240

10.  A Nonsynonymous SNP Catalog of Mycobacterium tuberculosis Virulence Genes and Its Use for Detecting New Potentially Virulent Sublineages.

Authors:  Natalya E Mikheecheva; Marina V Zaychikova; Alexander V Melerzanov; Valery N Danilenko
Journal:  Genome Biol Evol       Date:  2017-04-01       Impact factor: 3.416

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.